Danielle Valletti, Assistant Editor

Discover how innovative imaging detection methods, including MRI and proteomics, enhance breast cancer screening and support pharmacists in patient care.

Pharmacists play a crucial role in ensuring travelers receive essential vaccines, bridging gaps in immunization and enhancing global public health.

Breyanzi becomes the first FDA-approved CAR-T therapy for relapsed marginal zone lymphoma, offering hope with impressive response rates and durable outcomes.

Research reveals low-dose cannabinoids, like THC, may enhance serotonin levels and combat chronic inflammation in patients with HIV, offering new treatment possibilities.

Researchers explore how immune history and innovative vaccine technologies enhance protection against flu, highlighting pharmacists' vital role in patient education.

Researchers reveal fibroblasts as key players in hidradenitis suppurativa inflammation, paving the way for innovative treatment strategies.

The FDA approves Amneal's albuterol sulfate inhalation aerosol, enhancing access to vital asthma and COPD treatments for millions of Americans.

New research uncovers diverse tumor subgroups in triple-negative breast cancer, paving the way for personalized treatment strategies and improved patient outcomes.

Pharmacists remain essential to ensuring patients receive safe, effective, and accessible care amid expanding therapies.

New vaccine developments for Crimean-Congo hemorrhagic fever offer hope for prevention, highlighting pharmacists' crucial role in future vaccination efforts.

Discover how triple combination therapy for hypertension enhances cardiovascular health, as endorsed by the AHA and supported by pharmacists.

Explore the complexities of dietary supplement regulation, the importance of third-party testing, and how pharmacists can guide safe usage.

New studies reveal a modest, temporary increase in breast cancer risk linked to hormonal contraceptives, emphasizing the need for informed patient counseling.

Olezarsen effectively lowers triglycerides and enhances cardiovascular health, especially when combined with fibrates, benefiting pharmacists and patients alike.

New research reveals significant nonrespiratory complications in hospitalized children with influenza, highlighting the need for improved clinical awareness and antiviral treatment.

New triglyceride-lowering therapy Olezarsen significantly reduces severe hypertriglyceridemia and acute pancreatitis risk, offering hope for patients.

Measles resurges globally, threatening U.S. elimination status; pharmacists play a crucial role in vaccination efforts and outbreak response.

Guselkumab and paltusotine received FDA approval, Kenvue announced the new Tylenol Precise Pain-Relieving Patch, and a new generic version of mifepristone received the green light from the FDA.

Elinzanetant Showed Smaller Reductions in Bone Mineral Density Than Placebo

An expert highlights the need for early detection of aortic stenosis symptoms in elderly patients, urging pharmacists and clinicians to monitor subtle changes.

Biykem Bozkurt, MD, PhD, FACC, highlights the need for reliable activity monitoring in heart failure care, addressing challenges of digital wearables in clinical practice.

New research reveals GLP-1 receptor agonists like semaglutide offer heart failure benefits beyond weight loss, emphasizing pharmacists' crucial role in patient care.

Pharmacists play a crucial role in holistic healthcare, enhancing patient care through education and collaboration with allied health professionals.

Pharmacists enhance LDL cholesterol management with tailored solutions like enlicitide, improving patient adherence and outcomes in cardiovascular care.

Discover how objective activity monitoring with accelerometers transforms cardiovascular risk assessment and treatment evaluation, enhancing patient care for pharmacists.

Expert highlights the benefits of early combination therapy in hypertension management, emphasizing improved blood pressure control and reduced side effects.

Expert reveals ongoing disparities in heart valve disease care, stressing the need for improved diagnosis and treatment equity for vulnerable populations.

Boehringer Ingelheim showcases its commitment to cardio-kidney-metabolic research, highlighting innovative therapies and advancements at AHA 2025.

Discover how emerging therapies in cardio-kidney-metabolic health reshape disease management at AHA 2025, highlighting interconnected health pathways.

A new wrist-worn accelerometer device effectively monitors activity levels in heart failure patients, revealing critical insights into cardiovascular health.